These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2045427)

  • 1. Biocompatible controlled release polymers for delivery of polypeptides and growth factors.
    Langer R; Moses M
    J Cell Biochem; 1991 Apr; 45(4):340-5. PubMed ID: 2045427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery systems for angiogenesis stimulators and inhibitors.
    Langer R
    EXS; 1992; 61():327-30. PubMed ID: 1377552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres.
    Perets A; Baruch Y; Weisbuch F; Shoshany G; Neufeld G; Cohen S
    J Biomed Mater Res A; 2003 Jun; 65(4):489-97. PubMed ID: 12761840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Smart' delivery systems for biomolecular therapeutics.
    Stayton PS; El-Sayed ME; Murthy N; Bulmus V; Lackey C; Cheung C; Hoffman AS
    Orthod Craniofac Res; 2005 Aug; 8(3):219-25. PubMed ID: 16022724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioerodible polymers for ocular drug delivery.
    Deshpande AA; Heller J; Gurny R
    Crit Rev Ther Drug Carrier Syst; 1998; 15(4):381-420. PubMed ID: 9736417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research and application of drug controlled release technique in tissue engineering].
    Wang SG; Cai Q; Lü Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Sep; 15(5):280-5. PubMed ID: 11761854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatibility of polymeric delivery systems for macromolecules.
    Langer R; Brem H; Tapper D
    J Biomed Mater Res; 1981 Mar; 15(2):267-77. PubMed ID: 7348718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabrication of nanoparticles within polymeric pores for controlled release of drug.
    Asif M; Arayne MS; Sultana N; Hussain F
    Pak J Pharm Sci; 2006 Jan; 19(1):73-84. PubMed ID: 16632458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth factor-delivery systems for tissue engineering: a materials perspective.
    Vasita R; Katti DS
    Expert Rev Med Devices; 2006 Jan; 3(1):29-47. PubMed ID: 16359251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrices and scaffolds for protein delivery in tissue engineering.
    Tessmar JK; Göpferich AM
    Adv Drug Deliv Rev; 2007 May; 59(4-5):274-91. PubMed ID: 17544542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained delivery of growth factors from methylidene malonate 2.1.2-based polymers.
    Désiré L; Mysiakine E; Bonnafous D; Couvreur P; Sagodira S; Breton P; Fattal E
    Biomaterials; 2006 Apr; 27(12):2609-20. PubMed ID: 16364430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research advances in the controlled release of growth factor related to blood vessel tissue engineering].
    Wu L; Yuan X; Yao K
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Aug; 23(4):911-4. PubMed ID: 17002137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable polymers in controlled drug delivery.
    Heller J
    Crit Rev Ther Drug Carrier Syst; 1984; 1(1):39-90. PubMed ID: 6400195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
    Reza MS; Quadir MA; Haider SS
    J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled diffusional release of dispersed solute drugs from biodegradable implants of various geometries.
    Collins R; Paul Z; Reynolds DB; Short RF; Wasuwanich S
    Biomed Sci Instrum; 1997; 33():137-42. PubMed ID: 9731349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release of growth hormone from thermosensitive triblock copolymer systems: In vitro and in vivo evaluation.
    Chen S; Singh J
    Int J Pharm; 2008 Mar; 352(1-2):58-65. PubMed ID: 18036752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of cerebral vasospasm with biocompatible controlled-release systems for intracranial drug delivery.
    Omeis I; Neil JA; Murali R; Abrahams JM
    Neurosurgery; 2008 Dec; 63(6):1011-9; discussion 1019-21. PubMed ID: 19057314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling the release of proteins/peptides via the pulmonary route.
    Shoyele SA
    Methods Mol Biol; 2008; 437():141-8. PubMed ID: 18369966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of biocompatible poly(organophosphazenes) aiming for local delivery of protein drugs.
    Seong JY; Jun YJ; Kim BM; Park YM; Sohn YS
    Int J Pharm; 2006 May; 314(1):90-6. PubMed ID: 16549280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.